Stoke Therapeutics hauls in $40 mln Series A
Bedford, Massachusetts-based Stoke Therapeutics Inc, which works to increase gene expression to treat diseases caused by genetic insufficiency, has raised $40 million in Series A financing. Apple Tree Partners led the round.
4 January 2018•1 min read
